XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash Flows From Operating Activities:              
Consolidated Net Income $ 13,800 $ 10,311 $ 13,800 $ 10,311 $ 36,288 $ 40,068  
Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:              
Provision for Loan Losses     3,273 1,147 7,835 6,747 $ 8,047
Depreciation and Amortization         3,642 3,117  
Net Accretion of Purchase Accounting Adjustments         (4,109) (5,991)  
Stock Based Compensation Cost         2,372 2,059  
Net Amortization of Securities         4,632 5,242  
Loss on Sales of Securities         46 66  
Gain on Sale of Loans         (347) (9,179)  
Income on Other Equity Securities         (792) (2,074)  
Loss on Sale of Other Real Estate Owned, Net of Writedowns         95 1,369  
Increase in Cash Value of Life Insurance         (1,405) (1,029)  
Deferred Income Tax Expense (Benefit)         (2,651) 617  
Changes in Assets and Liabilities:              
(Increase) Decrease in Accrued Interest Receivable         (254) 4,870  
(Increase) Decrease in Other Assets         6,446 (5,503)  
Decrease in Accrued Interest Payable         (550) (664)  
Increase in Other Liabilities         6,949 2,074  
Net Cash Provided by Operating Activities         58,197 41,789  
Cash Flows From Investing Activities:              
Purchases of Securities Available for Sale         (82,380) (499,686)  
Proceeds from Maturities / Sales of Securities Available for Sale         35,197 22,206  
Proceeds from Paydowns of Securities Available for Sale         72,248 72,150  
Net Cash Received (Paid) in Acquisition         163,460 (7,256)  
Purchases of Other Equity Securities         (18,076) (3,084)  
Redemption of Other Equity Securities         3,215 2,549  
Purchase of Life Insurance         (15,000) (15,000)  
Proceeds from Death Benefit of Cash Value of Life Insurance         188 1,974  
Proceeds from Sale of SBA PPP Loans         0 243,607  
Net Increase in Loans         (897,943) (305,615)  
Net Purchases of Premises and Equipment         (7,193) (1,050)  
Loss on Disposal of Premises and Equipment         717 0  
Proceeds from Sales of Other Real Estate         646 6,873  
Net Decrease in Federal Funds Sold         215,907 169,506  
Net Cash Used in Investing Activities         (529,014) (312,826)  
Cash Flows From Financing Activities:              
Net Increase in Deposits         31,587 152,298  
Net Increase in Securities Sold Under Agreements to Repurchase         2,951 5,370  
Net Increase in Federal Funds Purchased         0 16,087  
Net Advances on Federal Home Loan Bank Borrowings         451,162 5,000  
Net Proceeds (Repayments) of Short Term Borrowings         4,989 (5,000)  
Net Repayments from Long Term Borrowings         0 (6,000)  
Proceeds from Issuance of Subordinated Debt         0 52,500  
Proceeds from Issuance of Preferred Stock         72,010 0  
Proceeds from Issuance of Common Stock         427 3,210  
Surrendered Shares of Options Exercised         (187) (2,276)  
Repurchase of Common Stock         0 (10,923)  
Payment of Dividends on Common Stock         (7,826) (6,999)  
Net Cash Provided by Financing Activities         555,113 203,267  
Net Increase (Decrease) in Cash and Cash Equivalents         84,296 (67,770)  
Cash and Cash Equivalents at Beginning of Period         68,375 149,131 149,131
Cash and Cash Equivalents at End of Period 152,671 81,361 $ 152,671 $ 81,361 152,671 81,361 $ 68,375
Supplemental Disclosures for Cash Flow Information:              
Interest on Deposits         11,558 10,134  
Interest on Borrowings         6,865 3,137  
Income Tax Payments         8,065 12,540  
Supplemental Schedule for Noncash Investing and Financing Activities:              
Change in the Unrealized Gain (Loss) on Securities Available for Sale         (106,728) (6,136)  
Change in the Unrealized Gain (Loss) on Equity Securities $ (38) $ (185)     1,041 (43)  
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale         22,194 1,298  
Transfer of Loans to Other Real Estate         154 1,343  
Acquisitions:              
Fair Value of Tangible Assets Acquired         531,510 1,343  
Other Intangible Assets Acquired         3,875 4,300  
Liabilities Assumed         508,991 6  
Net Identifiable Assets Acquired Over Liabilities Assumed         26,394 5,637  
Subordinated Debt Issued as Part of Consideration of Smith Shellnut Wilson         $ 0 $ 3,927